Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jul 14, 2012; 18(26): 3389-3399
Published online Jul 14, 2012. doi: 10.3748/wjg.v18.i26.3389
Published online Jul 14, 2012. doi: 10.3748/wjg.v18.i26.3389
Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner
Renee J Phillips, Karla J Helbig, Kylie H Van der Hoek, Michael R Beard, School of Molecular and Biomedical Science, The University of Adelaide, 5000 Adelaide, Australia
Renee J Phillips, Karla J Helbig, Kylie H Van der Hoek, Michael R Beard, Centre for Cancer Biology SA Pathology, 5000 Adelaide, Australia
Devanshi Seth, Drug Health Services, Royal Prince Alfred Hospital, 2050 Camperdown, Australia
Author contributions: Helbig KJ and Beard MR designed the research; Phillips RJ, Helbig KJ, Van der Hoek KH and Seth D performed the experiments and analysed data; Phillips RJ, Helbig KJ and Beard MR wrote the paper.
Supported by The NH and MRC of Australia
Correspondence to: Michael R Beard, PhD, School of Molecular and Biomedical Science, The University of Adelaide, North Terrace, 5005 Adeleide, Australia. michael.beard@adelaide.edu.au
Telephone: +61-8-83035522 Fax: +61-8-83037532
Received: January 5, 2012
Revised: March 23, 2012
Accepted: March 29, 2012
Published online: July 14, 2012
Revised: March 23, 2012
Accepted: March 29, 2012
Published online: July 14, 2012
Core Tip